WCMNY
GSK icon

Westchester Capital Management (New York)’s GSK GSK Stock Holding History

Westchester Capital Management (New York)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,147,120
Closed -$62.4M – 480
2022
Q2 		$62.4M Buy
1,147,120
+424,480
+59% +$23.4M 1.74% 15
2022
Q1 		$39.3M Buy
722,640
+667,280
+1,205% +$36.2M 1.07% 22
2021
Q4 		$3.05M Buy
+55,360
New +$2.88M 0.09% 165

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Westchester Capital Management (New York)'s GSK Position: Q3 2022 in Review

Westchester Capital Management (New York) sold out of GSK (GSK) in Q3 2022, closing a stake of 859,456 shares — an estimated $46.8M sold.

Westchester Capital Management (New York) first reported a position in GSK in Q4 2021 and held it in 3 quarters. The position peaked at $46.8M in Q2 2022. 743 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • Westchester Capital Management (New York) reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 859,456 GSK shares in Q3 2022, an estimated $46.8M.
  • Westchester Capital Management (New York) first reported a position in GSK in Q4 2021 and held it in 3 quarters.
  • Westchester Capital Management (New York)'s GSK position peaked at $46.8M in Q2 2022.
  • 743 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2022, filed 15 Nov 2022.